9.42BMarket Cap
LossP/E TTM
Cytokinetics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Cytokinetics Inc is 9.30, ranking 22 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -11.27, which is -57.00% below the recent high of -4.85 and -75.90% above the recent low of -19.82.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.